hydroxyurea has been researched along with Sarcoma, Clear Cell in 1 studies
Sarcoma, Clear Cell: A sarcoma of young adults occurring in the lower extremities and acral regions. It is found intimately bound to tendons as a circumscribed but unencapsulated melanin-bearing tumor of neuroectodermal origin. Clear cell sarcoma is associated with a specific t(12;22)(q13;q12) translocation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyurea (HU) is a ribonucleotide reductase inhibitor which blocks DNA excision-repair by the depletion of intracellular ribonucleotides." | 6.67 | A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma. ( Carmichael, J; Ganesan, TA; Harris, AL; Philip, PA; Tonkin, K, 1994) |
| "Hydroxyurea (HU) is a ribonucleotide reductase inhibitor which blocks DNA excision-repair by the depletion of intracellular ribonucleotides." | 2.67 | A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma. ( Carmichael, J; Ganesan, TA; Harris, AL; Philip, PA; Tonkin, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philip, PA | 1 |
| Carmichael, J | 1 |
| Tonkin, K | 1 |
| Ganesan, TA | 1 |
| Harris, AL | 1 |
1 trial available for hydroxyurea and Sarcoma, Clear Cell
| Article | Year |
|---|---|
A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dacarbazine; Female; Ga | 1994 |